ArticleInternational journal of epidemiology2018

Authors' reply to commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs.

James M Brophy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.